Department of Epidemiology of the Regional Health Service - Lazio

23/03/2010
22/06/2018
Institution
Outdated
EU Institution/Body/Agency
Download as PDF
Institution identification

Institution ID

24593

Institution full name and acronym

Department of Epidemiology of the Regional Health Service - Lazio

Institution countries

Italy

Type of institution

EU Institution/Body/Agency

Institution role

Data holder
Researcher

Institution website

ENCePP partner

Yes
Institution description
The Department of Epidemiology is a regional reference centre for epidemiological issues, comprising pharmacoepidemiology. The multidisciplinary team of physicians, pharmacists, biologista, statisticians, mathematicians and others have access to the regional administrative healthcare data.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
No

Contact details

Studies conducted by the institution

ACCESS template protocol for safety of COVID-19 vaccines
An epidemiological investigation of high-risk children for Respiratory Syncytial Virus infections - RWE palivizumab utilization as a RSV preventive treatment in Lazio (Italy)
Comparative Effectiveness and Safety of Drugs used in Rare Neuromuscular and Neurodegenerative Diseases (CAESAR)
Comparative Effectiveness and Safety of Immunosuppressive Drugs in Transplant patients (CESIT)
DISPARITIES IN LUNG CANCER MANAGEMENT IN ITALY: A PUBLIC HEALTH STUDY
Long-term outcomes and adverse events of therapy with inhaled corticosteroids, long-acting beta-2-agonists and anticholinergic drugs in hospitalised patients with Chronic Obstructive Pulmonary Disease (COPD) - a cohort study based on health information systems in three Italian regions (OUTPUL)
Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources (CVM Covid19-Vaccine-Monitor-EHR)
Switch pattern of biological drugs (originator and biosimilars) for the treatment of chronic immune-mediated inflammatory diseases through an Italian network of regional administrative databases: the VALORE Project
The BRodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) study in electronic healthcare databases